1Department of Chemical Engineering, University of Texas at Austin, Austin, TX USA
2Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERMF-75015, Paris, France
3Experimental Neuropathology Unit, Infection and Epidemiology Department, Institut Pasteur, 25, rue du Docteur Roux, 75015 Paris, France
4Limoges University, Limoges, France
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY USA
6Thayer School of Engineering, Dartmouth College, Hanover, NH USA
7Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI USA
8Department of Chemical Engineering, University of Michigan, Ann Arbor, MI USA
9Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI USA
10Department of Bioengineering, University of California at Los Angeles, Los Angeles, CA USA
11Department of Molecular Bioscience, University of Texas at Austin, Austin, TX USA
12Department of Biomedical Engineering, University of Texas at Austin, Austin, TX USA
13Present Address: Department of Applied Chemistry, Kookmin University, Seoul, Republic of Korea
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.